Leukemia Clinical Trials

Showing 1661-1680 of 10,987 trials

TRAIN-BW: Backward Walking Training in Multiple Sclerosis

NCT04091464

Individuals with multiple sclerosis (MS) experience in impairments in mobility and cognition that increase the risk for accidental falls. More than 50% of individuals with MS experience injurious falls within a 6-month period. Current interventions to improve fall risk have focused on forward walking (FW) and balance training, resulting in small declines in the relative risk for falls with a large degree of variability. Interestingly, motor differences between MS and healthy controls are more pronounced in backward walking (BW), yet no studies have investigated BW training as an intervention to reduce fall risk in persons with MS. This study will investigate the feasibility, acceptability and impact of BW training compared to forward walking training on motor function and fall risk in persons with MS.

Multiple SclerosisGait Disorders, NeurologicAccidental Fall

Wayne State University90 participantsStarted Jan 2020

Detroit, Michigan, United States

COMPLETEDNA

Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency

NCT02553447

This randomized pilot early phase I trial studies how well cholecalciferol works in treating patients with newly diagnosed non-Hodgkin lymphoma or chronic lymphocytic leukemia with low levels of vitamin D (vitamin D deficiency). Cholecalciferol may increase levels of vitamin D and improve survival in patients with non-Hodgkin lymphoma or chronic lymphocytic leukemia receiving standard of care chemotherapy.

Chronic Lymphocytic LeukemiaNon-Hodgkin LymphomaUntreated Chronic Lymphocytic Leukemia+1 more

University of Nebraska197 participantsStarted Oct 2015

Omaha, Nebraska, United States

TRAIN-BW: Backward Walking Training in Multiple Sclerosis

Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency

Related Searches

A Phase II Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics/Pharmacodynamics of JSKN033 in Patients With Advanced Non-Small Cell Lung Cancer

Short-term Psychodynamic Psychotherapy in Serious Physical Illness

Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever

Biometric Changes After Intervention of Anterior Chamber Angle : an Observational Study

Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers

Study of Oral Food Challenge Biomarkers (SAFER)

To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT

ADCT-602 in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia

UNITY VCS Vitreoretinal Surgery

Virtual Versus In-Person Approaches

Safety and Tolerability of Hepatocyte-like Cell Therapy for Liver Failure and Small-for-Size Syndrome

Autologous Bedside CD19 CAR T-cell Therapy for B-ALL

Evaluation of a Fall Detection Device in Isolated Elderly

Enfamil NeuroPro Study

Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies

A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients